article thumbnail

Synthesised sea sponge molecule could fight Parkinson’s

Drug Discovery World

Organic chemists at t he University of California, Los Angeles (UCLA) have created the first synthetic version of a molecule recently discovered in a sea sponge that may have therapeutic benefits for Parkinson’s disease and similar disorders.

article thumbnail

Following our pole star to a transformative collaboration

Dark Matter Blog

Most people, and in particular most investors we spoke to in those early days, thought we were nuts – that RNA lacked the structural and molecular complexity that medicinal chemistry exploits with such great effect for proteins. One is that molecular recognition is purely a matter of physics and RNA has to play by the same rules.

RNA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Enthera Pharmaceuticals Appoints Kazumi Shiosaki to Its Board of Directors and Lisa Olson to Its Scientific Advisory Board to Push Forward Company Growth and Development

The Pharma Data

She is currently the CEO of Twentyeight-Seven, a biotech company focused on novel RNA biology that she co-founded alongside prominent Harvard investigators. Kazumi holds a PhD in Synthetic Chemistry from UC Berkeley. Kazumi brings experience as both an entrepreneur and an investor within the field of biotechnology.

article thumbnail

Synthetic Origins

Codon

It really fits perfectly, and it is analogous to chemistry, where you've got synthetic chemistry and analytical chemistry. The RNA Exporter , which was developed by Felix Horns and others in my lab, is one example. The RNA Exporter also led to another application, which is related to the delivery issue.

RNA 58